close

TECHNE Corporation and its subsidiaries engage in the development and manufacture of biotechnology products, and hematology calibrators and controls primarily in the United States and Europe. The company's biotechnology product line includes Cytokines, extracted from natural sources or produced using recombinant DNA technology; Enzymes and related factors including enzyme substrates and inhibitors; antibodies, proteins produced by the immune system of an animal; assay kits, such as human and animal Quantikine kits, which allow research scientists to quantify the amount of a specific analyte; clinical diagnostic kits, including erythropoietin, transferrin receptor, and Beta2-microglobulin immunoassays; flow cytometry products consisting of fluorochrome labeled antibodies and Fluorokine kits, which measure the presence or absence of cell surface receptors for specific cytokines by flow cytometry; and intracellular cell signaling products, including antibodies, phospho-specific antibodies, antibody protein arrays, active caspases, kinases, phosphatases, and ELISA assays. The hematology product line comprises whole blood CBC controls/calibrators; linearity and reportable range controls that provide a means of assessing the linearity of hematology analyzers for white blood cells, red blood cells, platelets, and reticulocytes; whole blood reticulocyte controls for manual and automated counting of reticulocytes; whole blood flow cytometry controls for flow cytometry instruments; whole blood glucose/hemoglobin control to monitor instruments which measure glucose and hemoglobin in whole blood; erythrocyte sedimentation rate control to monitor erythrocyte sedimentation rate tests; and multi-purpose platelet reference controls for use by automated and semi-automated analyzers. TECHNE Corporation sells its products to research and clinical diagnostics markets. The company was founded in 1976 and is based in Minneapolis, Minnesota.

(login to add this stock to your watchlist or favorites)

Key Statistics

Closing Price	70.00
Volume	200752
Volume Avg	123118
52 Week High	86.43
52 Week Low	62.04
PE	23.24
PE (group average)	39
EPS Year	3.04
EPS change Q/Q	16.67%
EPS change Q/Q Yr ago	-3.45%
EPS change Q/Q next Q est	-2.33%
EPS change Y/Y	-0.68%
REV change Q/Q	12.7%
REV change Q/Q Yr ago	8.53%
EPS next Q est	0.86
EPS next Y est	3.49
Divident Annual	1.10
Dividend Yield	1.57%